DBTX
Decibel Therapeutics Inc

282
Loading...
Loading...
Decibel Therapeutics, Inc. discovers and develops medicines to protect, repair, and restore hearing. The firm focuses on hearing disorders, including noise-induced hearing loss, residual hearing preservation or improved sound fidelity with cochlear implants, presbycusis or age-related hearing loss, tinnitus, a persistent ringing in the ears, and genetic hearing loss. It also offers drugs for pediatric cancer and cystic fibrosis patients who experience ototoxicity or hearing loss. The company was founded in October 2015 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Decibel Therapeutics Inc?
What is the 52-week high for Decibel Therapeutics Inc?
What is the 52-week low for Decibel Therapeutics Inc?
What is Decibel Therapeutics Inc stock price today?
What was Decibel Therapeutics Inc stock price yesterday?
What is the PE ratio of Decibel Therapeutics Inc?
What is the Price-to-Book ratio of Decibel Therapeutics Inc?
What is Decibel Therapeutics Inc's EBITDA?
What is the 50-day moving average of Decibel Therapeutics Inc?

Latest DBTX News

View
No DBTX news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.